CICC: Recent U.S. Bank Risk Events Do Not Yet Pose a Systemic Shock
According to ChainCatcher, citing Golden Ten Data, a research report from CICC stated that the recent risk events involving two US banks are smaller in both scale and severity compared to the previous round, and are more about localized individual credit risk events leading to emotional contagion, which does not yet constitute a systemic shock to the financial system. This incident reflects the trend of rising credit risk in a high interest rate environment, which may lead to a decline in risk appetite in the credit market and tighter lending conditions, thereby triggering further liquidity tightening. However, unless there are clear signs of an overall economic recession in the US, credit tightening may remain relatively moderate and is unlikely to develop into a "crisis" scenario.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US listing, plans to raise up to 100 millions dollars.
TRex Bio filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday, intending to raise up to 100 million USD through an initial public offering (IPO).
Sui crypto surges 14% – Why traders must watch $1.05 closely
